While StAR’s involvement in breast malignancy remains obscure, we recently reported that both StAR protein expression and E2 synthesis are profoundly higher in ER+/PR+ breast cancer cell lines, when compared their levels with either non-cancerous mammary epithelial cells or TNBC [5]. The gene discussed is STAR; the disease is breast carcinoma.